🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

40 results for “Atrium” Clear

  1. IVAC MUTANOME, RBL001/RBL002

    Atrium Therapeutics

    Melanoma

    phase 1 mab completed

    1 trial

  2. Nivolumab

    Atrium Therapeutics

    Brain and Nervous System

    phase 1 small molecule completed

    1 trial

  3. Novel Supplement Based Therapy

    Atrium Therapeutics

    Small Intestinal Bacterial Overgrowth

    phase 1 other terminated

    1 trial

  4. RBL001/RBL002

    Atrium Therapeutics

    Melanoma

    phase 1 mab completed

    1 trial

  5. SAR441000

    Atrium Therapeutics

    Metastatic Neoplasm

    phase 1 small molecule terminated

    1 trial

  6. Phenoxybenzamine

    Atrium Therapeutics

    Pheochromocytoma

    approved small molecule completed

    1 trial

  7. Rivastigmine

    Atrium Therapeutics

    Parkinson's Disease

    approved small molecule terminated

    1 trial

  8. Abciximab local infusion

    Atrium Therapeutics

    Acute Anterior Myocardial Infarction

    small molecule completed

    1 trial

  9. Cranberry

    Atrium Therapeutics

    Endotoxemia

    other completed

    1 trial

  10. High Dose Vitamin D

    Atrium Therapeutics

    Breast

    other completed

    1 trial

  11. NO Ultra

    Atrium Therapeutics

    Hypertension

    other completed

    1 trial

  12. Orthica Soft Multi Mini and Orthica Fish EPA Mini

    Atrium Therapeutics

    Psychiatric Hospitalization

    other completed

    1 trial

  13. Pharmacogenomic Testing with the "Global Diversity Array with Enhanced PGx"

    Atrium Therapeutics

    Cancer

    gene therapy active

    1 trial

  14. Polyphenol-rich extract

    Atrium Therapeutics

    Healthy Elderly

    other completed

    1 trial

  15. Resveratrol, curcumin

    Atrium Therapeutics

    Effect of Resveratrol and Curcumin on Inflammation

    other completed

    1 trial

  16. Wobenzym PS

    Atrium Therapeutics

    Sub-clinical Inflammation

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources